On Capitol Hill, antitrust bills advance as Khan stumbles

Antitrust enforcers have received mixed receptions on Capitol Hill in recent weeks.

Neill Averitt

Federal-state relations could use more structure, won’t get much

There are getting to be an awful lot of cooks clustered around the antitrust soup kettle. The question is what to do about it.

Current Issue: 949

Panelists at FTC hearings bashed for failing to disclose prior cases, clients

The Federal Trade Commission’s sweeping hearings on 21st century issues in antitrust and consumer protection continue to win plaudits from lawyers and academics, but some critics think the agency...

Slaughter says Dems can effect change at FTC; Simons willing to listen

Commissioners at the Federal Trade Commission often vote in step with members of their own party, especially when they’re in the minority.

AT&T-Time Warner documents show Delrahim took case personally sometimes

Insights into Makan Delrahim’s oversight of the government’s lawsuit to block AT&T’s acquisition of Time Warner — including his interpretation of key facts and critical conversations with...

Chopra wants tougher ‘consequences’ for tech giants, others over misconduct

Rohit Chopra has staked out an aggressive position on the five-member Federal Trade Commission, questioning a system where first-time violators of the FTC Act’s prohibitions against deceptive...

CVS-Aetna nod proves DOJ gun-shy on vertical deals, critics charge

When the Justice Department approved the merger of CVS Health and Aetna — subject to a divestiture — critics blasted the government’s action as paving the way for higher costs to consumers.

Antitrust enforcers get more firepower to take on pay-for-delay deals

Antitrust enforcers will have another weapon in their arsenal when going after drugmakers for anticompetitive practices because of a measure signed by President Donald Trump earlier this month.